| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 12.78% | Mizuho | $6 → $3 | Maintains | Neutral |
| 08/09/2023 | 163.16% | Craig-Hallum | $5 → $7 | Upgrades | Hold → Buy |
| 08/09/2023 | 125.56% | Roth MKM | → $6 | Upgrades | Neutral → Buy |
| 05/11/2023 | 125.56% | Mizuho | $7 → $6 | Maintains | Neutral |
| 05/08/2023 | 12.78% | Loop Capital | $4 → $3 | Downgrades | Hold → Sell |
| 03/24/2023 | 87.97% | B. Riley Securities | $7 → $5 | Maintains | Neutral |
| 03/17/2023 | 87.97% | Credit Suisse | $8 → $5 | Upgrades | Underweight → Neutral |
| 03/16/2023 | 125.56% | Craig-Hallum | → $6 | Downgrades | Buy → Hold |
| 03/16/2023 | 125.56% | Roth MKM | → $6 | Downgrades | Buy → Neutral |
| 03/16/2023 | 50.38% | Barclays | $11 → $4 | Maintains | Underweight |
| 03/03/2023 | 463.91% | Craig-Hallum | $13 → $15 | Upgrades | Hold → Buy |
| 11/16/2022 | 351.13% | Mizuho | $14 → $12 | Maintains | Neutral |
| 11/08/2022 | 351.13% | Mizuho | $14 → $12 | Maintains | Neutral |
| 11/08/2022 | 313.53% | Barclays | $16 → $11 | Maintains | Underweight |
| 10/24/2022 | 351.13% | B. Riley Securities | $17 → $12 | Maintains | Neutral |
| 09/23/2022 | 200.75% | Credit Suisse | → $8 | Initiates Coverage On | → Underperform |
| 09/13/2022 | 501.5% | Keybanc | → $16 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 463.91% | Loop Capital | → $15 | Downgrades | Buy → Hold |
| 08/09/2022 | 426.32% | Mizuho | $18 → $14 | Maintains | Neutral |
| 08/09/2022 | 463.91% | Loop Capital | → $15 | Downgrades | Buy → Hold |
| 07/26/2022 | 463.91% | Jefferies | $18 → $15 | Maintains | Hold |
| 05/23/2022 | 576.69% | Jefferies | $23 → $18 | Maintains | Hold |
| 05/10/2022 | 576.69% | Mizuho | $20 → $18 | Maintains | Neutral |
| 05/10/2022 | 839.85% | Roth Capital | → $25 | Upgrades | Neutral → Buy |
| 04/08/2022 | 1027.82% | Loop Capital | $23 → $30 | Maintains | Buy |
| 02/28/2022 | 576.69% | Barclays | $30 → $18 | Maintains | Underweight |
| 02/25/2022 | 651.88% | Mizuho | $32 → $20 | Maintains | Neutral |
| 02/25/2022 | — | Roth Capital | Downgrades | Buy → Neutral | |
| 02/25/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 02/25/2022 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 02/25/2022 | — | Needham | Downgrades | Buy → Hold | |
| 02/25/2022 | 689.47% | JP Morgan | $60 → $21 | Downgrades | Overweight → Neutral |
| 02/25/2022 | 651.88% | Evercore ISI Group | $75 → $20 | Downgrades | Outperform → In-Line |
| 02/25/2022 | 764.66% | B. Riley Securities | → $23 | Downgrades | Buy → Neutral |
| 02/25/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 01/28/2022 | 1103.01% | Mizuho | $40 → $32 | Maintains | Neutral |
| 01/27/2022 | 1027.82% | Barclays | $50 → $30 | Maintains | Underweight |
| 01/14/2022 | 1779.7% | Keybanc | $70 → $50 | Maintains | Overweight |
| 12/16/2021 | 1967.67% | Loop Capital | → $55 | Initiates Coverage On | → Buy |
| 12/14/2021 | 2155.64% | JP Morgan | $80 → $60 | Maintains | Overweight |
| 11/03/2021 | — | Mizuho | Downgrades | Buy → Neutral | |
| 11/03/2021 | 2531.58% | Keybanc | $78 → $70 | Maintains | Overweight |
| 10/21/2021 | 1779.7% | Barclays | → $50 | Downgrades | Equal-Weight → Underweight |
| 09/17/2021 | 2907.52% | Barclays | $76 → $80 | Maintains | Overweight |
| 08/04/2021 | 2381.2% | Needham | $71 → $66 | Maintains | Buy |
| 07/01/2021 | 2569.17% | Goldman Sachs | → $71 | Initiates Coverage On | → Neutral |
| 03/31/2021 | 2757.14% | Citigroup | → $76 | Initiates Coverage On | → Buy |
| 02/26/2021 | 3283.46% | Mizuho | $75 → $90 | Maintains | Buy |
| 02/26/2021 | 2719.55% | Rosenblatt | $73 → $75 | Maintains | Buy |
| 02/26/2021 | 2569.17% | Needham | $65 → $71 | Maintains | Buy |
| 02/26/2021 | 2869.92% | JP Morgan | → $79 | Upgrades | Neutral → Overweight |
| 01/19/2021 | 2681.95% | KeyBanc | $64 → $74 | Maintains | Overweight |
| 01/11/2021 | 2343.61% | Jefferies | $55 → $65 | Downgrades | Buy → Hold |
| 12/18/2020 | 2644.36% | Rosenblatt | → $73 | Initiates Coverage On | → Buy |
| 10/30/2020 | 2343.61% | Needham | $60 → $65 | Maintains | Buy |
| 08/05/2020 | 2155.64% | Benchmark | $50 → $60 | Maintains | Buy |
| 08/05/2020 | 2155.64% | Needham | $33 → $60 | Maintains | Buy |
| 08/05/2020 | 2306.02% | Keybanc | $48 → $64 | Maintains | Overweight |
| 07/20/2020 | 1742.11% | Barclays | $31 → $49 | Maintains | Overweight |
| 07/01/2020 | 1704.51% | Keybanc | $38 → $48 | Maintains | Overweight |
| 05/06/2020 | 1140.6% | JP Morgan | $40 → $33 | Maintains | Neutral |
| 05/06/2020 | 1253.38% | B. Riley Securities | $31 → $36 | Maintains | Buy |
| 05/06/2020 | 1403.76% | Mizuho | $30 → $40 | Maintains | Buy |
| 05/06/2020 | 1328.57% | Keybanc | $43 → $38 | Maintains | Overweight |
| 04/24/2020 | 1065.41% | Craig-Hallum | $35 → $31 | Maintains | Buy |
| 03/17/2020 | 1065.41% | B. Riley Securities | $51 → $31 | Maintains | Buy |
| 03/16/2020 | 1140.6% | Needham | $47 → $33 | Maintains | Buy |
| 02/14/2020 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 02/14/2020 | 1516.54% | Keybanc | $48 → $43 | Maintains | Overweight |
| 02/10/2020 | 1817.29% | B. Riley Securities | $42.5 → $51 | Reiterates | → Buy |
| 01/23/2020 | 1704.51% | Keybanc | $45 → $48 | Maintains | Overweight |
| 01/10/2020 | 1591.73% | Mizuho | → $45 | Initiates Coverage On | → Buy |
| 11/20/2019 | 1403.76% | JP Morgan | → $40 | Initiates Coverage On | → Neutral |
| 11/15/2019 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/08/2019 | 1629.32% | Benchmark | $40 → $46 | Maintains | Buy |
| 10/07/2019 | 1554.14% | Barclays | $36 → $44 | Maintains | Overweight |
| 08/20/2019 | 1591.73% | Keybanc | $39 → $45 | Maintains | Overweight |
| 08/01/2019 | 1366.17% | Keybanc | $36 → $39 | Maintains | Overweight |
| 07/12/2019 | 1253.38% | Keybanc | → $36 | Initiates Coverage On | → Overweight |
| 05/16/2019 | 1403.76% | Berenberg | → $40 | Initiates Coverage On | → Buy |
| 04/01/2019 | — | Jefferies | Initiates Coverage On | → Buy | |
| 03/25/2019 | 1366.17% | Piper Sandler | → $39 | Initiates Coverage On | → Overweight |
| 03/08/2019 | — | Barclays | Initiates Coverage On | → Overweight | |
| 03/07/2019 | — | Evercore ISI Group | Initiates Coverage On | → Outperform | |
| 01/24/2019 | 1065.41% | Oppenheimer | → $31 | Upgrades | Perform → Outperform |
| 12/21/2018 | 764.66% | Summit Insights Group | → $23 | Initiates Coverage On | → Buy |
What is the target price for LivePerson (LPSN)?
The latest price target for LivePerson (NASDAQ: LPSN) was reported by Mizuho on November 10, 2023. The analyst firm set a price target for $3.00 expecting LPSN to rise to within 12 months (a possible 12.78% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LivePerson (LPSN)?
The latest analyst rating for LivePerson (NASDAQ: LPSN) was provided by Mizuho, and LivePerson maintained their neutral rating.
When is the next analyst rating going to be posted or updated for LivePerson (LPSN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LivePerson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LivePerson was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating LivePerson (LPSN) correct?
While ratings are subjective and will change, the latest LivePerson (LPSN) rating was a maintained with a price target of $6.00 to $3.00. The current price LivePerson (LPSN) is trading at is $2.66, which is out of the analyst's predicted range.